Renal Manifestations of Fabry Disease: A Narrative Review
- PMID: 33786192
- PMCID: PMC7960898
- DOI: 10.1177/2054358120985627
Renal Manifestations of Fabry Disease: A Narrative Review
Abstract
Purpose of review: In this narrative review, we describe general aspects, histological alterations, treatment, and implications of Fabry disease (FD) nephropathy. This information should be used to guide physicians and patients in a shared decision-making process.
Source of information: Original peer-reviewed articles, review articles, and opinion pieces were identified from PubMed and Google Scholar databases. Only sources in English were accessed.
Methods: We performed a focused narrative review assessing the main aspects of FD nephropathy. The literature was critically analyzed from a theoretical and contextual perspective, and thematic analysis was performed.
Key findings: FD nephropathy is related to the progressive accumulation of GL3, which occurs in all types of renal cells. It is more prominent in podocytes, which seem to play an important role in the pathogenesis of this nephropathy. A precise detection of renal disorders is of fundamental importance because the specific treatment of FD is usually delayed, making reversibility unlikely and leading to a worse prognosis.
Limitations: As no formal tool was applied to assess the quality of the included studies, selection bias may have occurred. Nonetheless, we have attempted to provide a comprehensive review on the topic using current studies from experts in FD and extensive review of the literature.
Objet de la revue: Dans cette revue narrative, nous discutons des aspects généraux, des modifications histologiques, du traitement et des implications de la néphropathie liée à la Maladie de Fabry. Des informations qui serviront à guider les médecins et les patients dans un processus commun de prise de décision.
Sources: Les originaux d’articles évalués par les pairs, d’articles-synthèses et d’articles d’opinion ont été répertoriés dans les bases de données Pubmed et Google Scholar. Seuls les articles en anglais ont été consultés.
Méthodologie: Nous avons procédé à une revue narrative ciblée examinant les principaux aspects de la néphropathie liés à la maladie de Fabry. La documentation a fait l’objet d’une critique rigoureuse du point de vue théorique et contextuel, et une analyse thématique a été effectuée.
Principaux résultats: La néphropathie liée à la maladie de Fabry est associée à l’accumulation progressive de GL3, qui se produit dans tous les types de cellules rénales. Elle est plus présente dans les podocytes, qui semblent jouer un rôle important dans la pathogenèse de la néphropathie. Un dépistage précis des troubles rénaux est d’une importance capitale puisque le traitement spécifique de la maladie de Fabry est généralement retardé, ce qui rend la réversibilité peu probable et conduit à un pronostic plus défavorable.
Limites: Des biais de sélection pourraient s’être introduits puisqu’aucun outil formel n’a été utilisé pour évaluer les études incluses. Nous avons néanmoins tenté de procéder à un examen complet du sujet grâce aux études actuelles menées par des experts de la maladie de Fabry et à une revue approfondie de la documentation.
Keywords: Fabry; chronic kidney disease; end-stage renal disease; kidney disease; renal failure.
© The Author(s) 2021.
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures




Similar articles
-
Barriers to Education and Shared Decision Making in the Chronic Kidney Disease Population: A Narrative Review.Can J Kidney Health Dis. 2018 Nov 2;5:2054358118803322. doi: 10.1177/2054358118803322. eCollection 2018. Can J Kidney Health Dis. 2018. PMID: 30542621 Free PMC article. Review.
-
Anderson-Fabry disease: a multiorgan disease.Curr Pharm Des. 2013;19(33):5974-96. doi: 10.2174/13816128113199990352. Curr Pharm Des. 2013. PMID: 23448451 Review.
-
Accumulation of Globotriaosylceramide in Podocytes in Fabry Nephropathy Is Associated with Progressive Podocyte Loss.J Am Soc Nephrol. 2020 Apr;31(4):865-875. doi: 10.1681/ASN.2019050497. Epub 2020 Mar 3. J Am Soc Nephrol. 2020. PMID: 32127409 Free PMC article.
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
Fabry Nephropathy: An Evidence-Based Narrative Review.Kidney Blood Press Res. 2018;43(2):406-421. doi: 10.1159/000488121. Epub 2018 Mar 16. Kidney Blood Press Res. 2018. PMID: 29558749 Review.
Cited by
-
Prevalence of Kidney and Urinary Tract Complications in Fabry Disease from 2000 to 2020: A Global Cohort Study Including 10,637 Patients.In Vivo. 2023 Nov-Dec;37(6):2609-2617. doi: 10.21873/invivo.13368. In Vivo. 2023. Retraction in: In Vivo. 2024 Jul-Aug;38(4):2097. doi: 10.21873/invivo.13670. PMID: 37905636 Free PMC article. Retracted.
-
Pathologic findings of Fabry nephropathy: the pivotal role of kidney biopsy.Kidney Res Clin Pract. 2021 Dec;40(4):508-511. doi: 10.23876/j.krcp.21.235. Epub 2021 Dec 3. Kidney Res Clin Pract. 2021. PMID: 34922427 Free PMC article. No abstract available.
-
Gene Expression Analysis in gla-Mutant Zebrafish Reveals Enhanced Ca2+ Signaling Similar to Fabry Disease.Int J Mol Sci. 2022 Dec 26;24(1):358. doi: 10.3390/ijms24010358. Int J Mol Sci. 2022. PMID: 36613802 Free PMC article.
-
Palm-Plant Pain, Sign of a Severe Systemic Disease? Case Report and Review of Literature.Genes (Basel). 2023 Feb 17;14(2):516. doi: 10.3390/genes14020516. Genes (Basel). 2023. PMID: 36833443 Free PMC article. Review.
-
Clinical Characteristics, Renal Involvement, and Therapeutic Options of Pediatric Patients With Fabry Disease.Front Pediatr. 2022 Jun 1;10:908657. doi: 10.3389/fped.2022.908657. eCollection 2022. Front Pediatr. 2022. PMID: 35722479 Free PMC article. Review.
References
-
- Desnick RJ, Ioannou YA, Eng CM. α-Galactosidase A Deficiency: Fabry Disease. The Online Metabolic and Molecular Bases of Inherited Disease. New York. McGraw Hill; 2014:1-64.
-
- Schiffmann R. Fabry disease. Handb Clin Neurol. 2015;132:231-248. - PubMed
-
- The human gene mutation database. http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GLA. Accessed in May 2020.
-
- Curiati MA, Aranda CS, Kyosen SO, et al.. The challenge of diagnosis and indication for treatment in Fabry disease. J Inborn Errors Metab Screen. 2017;5:1-7.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials